Cargando…
Neoadjuvant Chemotherapy Versus Direct Surgery for Locally Advanced Gastric Cancer With Serosal Invasion (cT4NxM0): A Propensity Score-Matched Analysis
BACKGROUND: For locally advanced gastric cancer (LAGC) with serosal invasion (cT4NxM0), adjuvant chemotherapy (AC) after D2 gastrectomy is the standard therapy in Asia. However, perioperative chemotherapy (PCT) combined with D2 gastrectomy is mostly suggested in Europe and America. As a part of PCT,...
Autores principales: | Xu, Wei, Wang, Lingquan, Yan, Chao, He, Changyu, Lu, Sheng, Ni, Zhentian, Hua, Zichen, Zhu, Zhenglun, Sah, Birendra Kumar, Yang, Zhongyin, Zheng, Yanan, Feng, Runhua, Li, Chen, Yao, Xuexin, Chen, Mingmin, Liu, Wentao, Yan, Min, Zhu, Zhenggang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419416/ https://www.ncbi.nlm.nih.gov/pubmed/34497768 http://dx.doi.org/10.3389/fonc.2021.718556 |
Ejemplares similares
-
Is D2 Lymphadenectomy Alone Suitable for Gastric Cancer With Bulky N2 and/or Para-Aortic Lymph Node Metastases After Preoperative Chemotherapy?
por: Xu, Wei, et al.
Publicado: (2021) -
Prediction Model of Tumor Regression Grade for Advanced Gastric Cancer After Preoperative Chemotherapy
por: Xu, Wei, et al.
Publicado: (2021) -
Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases
por: Shi, Min, et al.
Publicado: (2021) -
Complications and risk factors for complications of implanted subcutaneous ports for intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis
por: Yang, Zhongyin, et al.
Publicado: (2020) -
Preoperative mediastinal staging in patients with cT1‐3NxM0 non‐small cell lung cancer
por: Steunenberg, Bastiaan E., et al.
Publicado: (2020)